Search the collection

1,197 results for Tislelizumab

Sort by:

Sort by

Limit results to:

20 per page

1,197 results for Tislelizumab

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Tislelizumab: First Approval
Author / Creator:Lee, Arnold ; Keam, Susan J.
Publisher:Cham: Springer International Publishing
Journal title:Drugs (New York, N.Y.), 2020-04, Vol.80 (6), p.617-624
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Comparative efficacy of tislelizumab plus lenvatinib and tislelizumab alone against advanced hepatocellular carcinoma after lenvatinib failure: a real-world study
Author / Creator:Yang, Jiajin ; Xu, Qiuping ; Luo, Sihao ; Wu, Jianbing
Publisher:England: BioMed Central Ltd
Journal title:BMC cancer, 2025-04, Vol.25 (1), p.708-10, Article 708
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Neoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma: the Notable-HCC phase 1b trial
Author / Creator:Li, Zhongchao ; Liu, Jing ; Zhang, Bo ; Yue, Jinbo ; Shi, Xuetao ; Cui, Kai ; Liu, Zhaogang ; Chang, Zhibin ; Sun, Zhicheng ; Li, Mingming ; Yang, Yue ; Ma, Zhao ; Li, Lei ; Zhang, Chengsheng ; Sun, Pengfei ; Zhong, Jingtao ; Zhao, Lei
Publisher:London: Nature Publishing Group UK
Journal title:Nature communications, 2024-04, Vol.15 (1), p.3260-3260, Article 3260
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma
Author / Creator:Ye, Dingwei ; Liu, Jiyan ; Zhou, Aiping ; Zou, Qing ; Li, Hanzhong ; Fu, Cheng ; Hu, Hailong ; Huang, Jian ; Zhu, Shaoxing ; Jin, Jie ; Ma, Lulin ; Guo, Jianming ; Xiao, Jun ; Park, Se Hoon ; Zhang, Dahong ; Qiu, Xiusong ; Bao, Yuanyuan ; Zhang, Lilin ; Shen, Wei ; Bi, Feng
Publisher:England: John Wiley & Sons, Inc
Journal title:Cancer science, 2021-01, Vol.112 (1), p.305-313
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Tislelizumab uniquely binds to the CC′ loop of PD‐1 with slow‐dissociated rate and complete PD‐L1 blockage
Author / Creator:Hong, Yuan ; Feng, Yingcai ; Sun, Hanzi ; Zhang, Bo ; Wu, Hongfu ; Zhu, Qing ; Li, Yucheng ; Zhang, Tong ; Zhang, Yilu ; Cui, Xinxin ; Li, Zhuo ; Song, Xiaomin ; Li, Kang ; Liu, Mike ; Liu, Ye
Publisher:England: John Wiley & Sons, Inc
Journal title:FEBS open bio, 2021-03, Vol.11 (3), p.782-792
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-co...
Author / Creator:Xu, Jianming, Prof ; Kato, Ken, MD ; Raymond, Eric, Prof ; Hubner, Richard A, BM BCh ; Shu, Yongqian, Prof ; Pan, Yueyin, Prof ; Park, Sook Ryun, Prof ; Ping, Lu, MD ; Jiang, Yi, MD ; Zhang, Jingdong, Prof ; Wu, Xiaohong, MD ; Yao, Yuanhu, MD ; Shen, Lin, Prof ; Kojima, Takashi, Prof ; Gotovkin, Evgeny, MD ; Ishihara, Ryu, MD ; Wyrwicz, Lucjan, Prof ; Van Cutsem, Eric, Prof ; Jimenez-Fonseca, Paula, MD ; Lin, Chen-Yuan, MD ; Wang, Lei, MD ; Shi, Jingwen, PhD ; Li, Liyun, MD ; Yoon, Harry H, Prof
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2023-05, Vol.24 (5), p.483-495
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma
Author / Creator:Qin, Shukui ; Finn, Richard S ; Kudo, Masatoshi ; Meyer, Tim ; Vogel, Arndt ; Ducreux, Michel ; Macarulla, Teresa Mercade ; Tomasello, Gianluca ; Boisserie, Frederic ; Hou, Jeannie ; Li, Xin ; Song, James ; Zhu, Andrew X
Publisher:England: Future Medicine Ltd
Journal title:Future oncology (London, England), 2019-06, Vol.15 (16), p.1811-1822
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ArticlesPeer ReviewedFull Text
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial
Author / Creator:Al-Sawaf, Othman ; Ligtvoet, Rudy ; Robrecht, Sandra ; Stumpf, Janina ; Fink, Anna-Maria ; Tausch, Eugen ; Schneider, Christof ; Boettcher, Sebastian ; Mikusko, Martin ; Ritgen, Matthias ; Schetelig, Johannes ; von Tresckow, Julia ; Vehling-Kaiser, Ursula ; Gaska, Tobias ; Wendtner, Clemens Martin ; Chapuy, Bjoern ; Fischer, Kirsten ; Kreuzer, Karl-Anton ; Stilgenbauer, Stephan ; Staber, Philipp ; Niemann, Carsten ; Hallek, Michael ; Eichhorst, Barbara
Publisher:New York: Nature Publishing Group US
Journal title:Nature medicine, 2024-01, Vol.30 (1), p.240-248
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
ArticlesPeer ReviewedFull Text
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phas...
Author / Creator:Qiu, Miao-Zhen ; Oh, Do-Youn ; Kato, Ken ; Arkenau, Tobias ; Tabernero, Josep ; Correa, Marcia Cruz ; Zimina, Anastasia V ; Bai, Yuxian ; Shi, Jianhua ; Lee, Keun-Wook ; Wang, Jufeng ; Poddubskaya, Elena ; Pan, Hongming ; Rha, Sun Young ; Zhang, Ruixing ; Hirano, Hidekazu ; Spigel, David ; Yamaguchi, Kensei ; Chao, Yee ; Wyrwicz, Lucjan ; Disel, Umut ; Cid, Roberto Pazo ; Fornaro, Lorenzo ; Evesque, Ludovic ; Wang, Hongwei ; Xu, Yaling ; Li, Jiang ; Sheng, Tao ; Yang, Silu ; Li, Liyun ; Moehler, Markus ; Xu, Rui-Hua
Publisher:England: British Medical Journal Publishing Group
Journal title:BMJ (Online), 2024-05, Vol.385, p.e078876
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
ArticlesPeer ReviewedFull Text
Cost‑effectiveness analysis of tislelizumab plus chemotherapy in Chinese patients with advanced or metastatic oesophageal squamous cell carcinoma
Author / Creator:Zhang, Li ; Su, Henghai ; Liang, Xueyan ; Chen, Xiaoyu ; Li, Yan
Publisher:London: Nature Publishing Group UK
Journal title:Scientific reports, 2024-07, Vol.14 (1), p.17734-10, Article 17734
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
ArticlesPeer ReviewedFull Text
Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study
Author / Creator:Song, Yuqin ; Gao, Quanli ; Zhang, Huilai ; Fan, Lei ; Zhou, Jianfeng ; Zou, Dehui ; Li, Wei ; Yang, Haiyan ; Liu, Ting ; Wang, Quanshun ; Lv, Fangfang ; Guo, Haiyi ; Yang, Liudi ; Elstrom, Rebecca ; Huang, Jane ; Novotny, William ; Wei, Vivian ; Zhu, Jun
Publisher:London: Nature Publishing Group UK
Journal title:Leukemia, 2020-02, Vol.34 (2), p.533-542
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesPeer ReviewedFull Text
Inflammatory markers predict survival in patients with postoperative urothelial carcinoma receiving tislelizumab (PD-1 inhibitor) adjuvant therapy
Author / Creator:Yang, Meng ; Zhang, Jingwen ; Wei, Dongqun ; Yu, Tianyi ; Chen, Zeyu ; Liu, Xin ; Zhu, Haitao
Publisher:England: BioMed Central Ltd
Journal title:BMC cancer, 2024-02, Vol.24 (1), p.196-196, Article 196
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
ArticlesFull Text
Tislelizumab: Immune-related myocarditis: case report
Publisher:Cham: Springer International Publishing
Journal title:Reactions weekly, 2020-07, Vol.1813 (1), p.217-217
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
ArticlesPeer ReviewedFull Text
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors
Author / Creator:Desai, Jayesh ; Deva, Sanjeev ; Lee, Jong Seok ; Lin, Chia-Chi ; Yen, Chia-Jui ; Chao, Yee ; Keam, Bhumsuk ; Jameson, Michael ; Hou, Ming-Mo ; Kang, Yoon-Koo ; Markman, Ben ; Lu, Chang-Hsien ; Rau, Kun-Ming ; Lee, Kyung-Hun ; Horvath, Lisa ; Friedlander, Michael ; Hill, Andrew ; Sandhu, Shahneen ; Barlow, Paula ; Wu, Chi-Yuan ; Zhang, Yun ; Liang, Liang ; Wu, John ; Paton, Virginia ; Millward, Michael
Publisher:London: BMJ Publishing Group Ltd
Journal title:Journal for immunotherapy of cancer, 2020-06, Vol.8 (1), p.e000453
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
ArticlesPeer ReviewedFull Text
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial
Author / Creator:Ren, Zhenggang ; Ducreux, Michel ; Abou-Alfa, Ghassan K. ; Merle, Philippe ; Fang, Weijia ; Edeline, Julien ; Li, Zhiwei ; Wu, Lihua ; Assenat, Eric ; Hu, Sheng ; Rimassa, Lorenza ; Zhang, Tao ; Blanc, Jean-Frédéric ; Pan, Hongming ; Ross, Paul ; Yen, Chia-Jui ; Tran, Albert ; Shao, Guoliang ; Bouattour, Mohamed ; Chen, Yajin ; Meyer, Tim ; Hou, Jinlin ; Tougeron, David ; Bai, Yuxian ; Hou, Ming-Mo ; Meng, Zhiqiang ; Wu, John ; Li, Vincent ; Chica-Duque, Sandra ; Cheng, Ann-Lii
Publisher:Basel, Switzerland: S. Karger AG
Journal title:Liver cancer (Basel ), 2023-02, Vol.12 (1), p.72-84
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
ArticlesPeer ReviewedFull Text
Expert Commentary on the Product Profile of Tislelizumab in Advanced Esophageal Cancer: Krystal Preston, PharmD, BCPS, spoke about the use of tislelizumab-jsgr
Author / Creator:Preston, Krystal
Publisher:Intellisphere, LLC
Journal title:Oncology (Williston Park, N.Y.), 2024-08, Vol.38 (8), p.315
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
ArticlesPeer ReviewedFull Text
Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model‐Based Approach
Author / Creator:Rizwan, Ahsan ; Giovinazzo, Hugh ; Yu, Tian ; Gao, Yuying ; Wang, Kun ; Xu, Fengyan ; Wan, Ya ; Wang, Jun ; Sahasranaman, Srikumar ; Campbell, Marcia ; Schnell, Patrick ; Abdrashitov, Ramil ; Hanley, William D. ; Budha, Nageshwar
Publisher:United States: John Wiley & Sons, Inc
Journal title:Clinical and translational science, 2025-05, Vol.18 (5), p.e70223-n/a
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
ArticlesPeer ReviewedFull Text
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial
Author / Creator:Friedlander, Michael, Prof ; Meniawy, Tarek, PhD ; Markman, Ben, MBBS ; Mileshkin, Linda, MD ; Harnett, Paul, Prof ; Millward, Michael, MBBS ; Lundy, Joanne, MBBS ; Freimund, Alison, MBBS ; Norris, Christie, RN ; Mu, Song, PhD ; Wu, John, PhD ; Paton, Virginia, PharmD ; Gao, Bo, PhD
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2019-09, Vol.20 (9), p.1306-1315
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
ArticlesPeer ReviewedFull Text
Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study
Author / Creator:Shen, Lin ; Guo, Jun ; Zhang, Qingyuan ; Pan, Hongming ; Yuan, Ying ; Bai, Yuxian ; Liu, Tianshu ; Zhou, Qing ; Zhao, Jun ; Shu, Yongqian ; Huang, Xiaoming ; Wang, Siyang ; Wang, Jie ; Zhou, Aiping ; Ye, Dingwei ; Sun, Ting ; Gao, Yujuan ; Yang, Silu ; Wang, Zuobai ; Li, Jian ; Wu, Yi-Long
Publisher:London: BMJ Publishing Group Ltd
Journal title:Journal for immunotherapy of cancer, 2020-06, Vol.8 (1), p.e000437
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
ArticlesPeer ReviewedFull Text
Cost-effectiveness analysis of Tislelizumab vs Sorafenib as the first-line treatment of unresectable hepatocellular carcinoma
Author / Creator:Chen, Qiuping ; Sun, Quan ; Zhang, Jing ; Li, Baixue ; Feng, Quansheng ; Liu, Jibin
Publisher:United States: Public Library of Science
Journal title:PloS one, 2024-03, Vol.19 (3), p.e0295090-e0295090
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 1,197 results

Export record to excel

Export this record

Export record to excel

Tislelizumab: First Approval

Export this record

Export record to excel

Comparative efficacy of tislelizumab plus lenvatinib and tislelizumab alone against advanced hepatocellular carcinoma after lenvatinib failure: a real-world study

Export this record

Export record to excel

Neoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma: the Notable-HCC phase 1b trial

Export this record

Export record to excel

Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma

Export this record

Export record to excel

Tislelizumab uniquely binds to the CC′ loop of PD‐1 with slow‐dissociated rate and complete PD‐L1 blockage

Export this record

Export record to excel

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-co...

Export this record

Export record to excel

RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma

Export this record

Export record to excel

Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial

Export this record

Export record to excel

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phas...

Export this record

Export record to excel

Cost‑effectiveness analysis of tislelizumab plus chemotherapy in Chinese patients with advanced or metastatic oesophageal squamous cell carcinoma

Export this record

Export record to excel

Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study

Export this record

Export record to excel

Inflammatory markers predict survival in patients with postoperative urothelial carcinoma receiving tislelizumab (PD-1 inhibitor) adjuvant therapy

Export this record

Export record to excel

Tislelizumab: Immune-related myocarditis: case report

Export this record

Export record to excel

Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors

Export this record

Export record to excel

Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial

Export this record

Export record to excel

Expert Commentary on the Product Profile of Tislelizumab in Advanced Esophageal Cancer: Krystal Preston, PharmD, BCPS, spoke about the use of tislelizumab-jsgr

Export this record

Export record to excel

Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model‐Based Approach

Export this record

Export record to excel

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

Export this record

Export record to excel

Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

Export this record

Export record to excel

Cost-effectiveness analysis of Tislelizumab vs Sorafenib as the first-line treatment of unresectable hepatocellular carcinoma

Refine your search